Devin Haney files lawsuit against Ryan Garcia in New York
- Devin Haney has filed a lawsuit against Ryan Garcia and Golden Boy Promotions, alleging battery, fraud, and breach of contract.
- The legal action stems from their April fight, which was declared a no-contest after Garcia tested positive for a banned performance-enhancing drug.
- The lawsuit raises significant questions about athlete safety and could lead to stricter regulations in boxing.
Devin Haney, the former undisputed lightweight champion, has initiated legal action against Ryan Garcia and Golden Boy Promotions in New York, alleging battery, fraud, and breach of contract related to their April title fight in Brooklyn. The bout, which initially resulted in a unanimous decision victory for Garcia, was later declared a no-contest after he tested positive for ostarine, a banned performance-enhancing substance. Haney claims he was unaware of Garcia's drug use and would not have participated in the fight had he known. The lawsuit outlines serious allegations, including battery due to the unfair nature of the contest and fraud based on Garcia's misleading statements regarding his weight. Haney's attorney emphasized that the boxer did not consent to fight an opponent who was under the influence of performance-enhancing drugs. The financial stakes are high, with Haney seeking unspecified damages for physical injuries, reputational harm, and emotional distress. The implications of this lawsuit extend beyond Haney and Garcia, potentially affecting the practices of Golden Boy Promotions and the boxing community at large. Haney's father and manager raised concerns about the fairness of the situation, questioning why Oscar De La Hoya could receive a fine while Haney suffers losses without compensation. As the case unfolds, it raises critical questions about athlete safety and the integrity of boxing, possibly leading to stricter regulations regarding drug use in the sport. The outcome could set a significant precedent for future cases involving performance-enhancing drugs in athletics.